Healthcare provider profile · identity verified

Amy Lee Bodeau, M.D., PH.D.

Family Practice · RIVERSIDE, CA · NPI 1518186774

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	459	174
Levothyroxine Sodium	Levothyroxine Sodium	387	125
Losartan Potassium	Losartan Potassium	347	108
Amlodipine Besylate	Amlodipine Besylate	322	111
Lisinopril	Lisinopril	272	92
Rosuvastatin Calcium	Rosuvastatin Calcium	245	89
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	211	42
Hydrochlorothiazide	Hydrochlorothiazide	195	70
Albuterol Sulfate Hfa	Albuterol Sulfate	179	81
Meloxicam	Meloxicam	177	67
Potassium Chloride	Potassium Chloride	172	56
Pantoprazole Sodium	Pantoprazole Sodium	164	44
Gabapentin	Gabapentin	163	59
Atenolol	Atenolol	144	45
Metoprolol Tartrate	Metoprolol Tartrate	144	56
Alendronate Sodium	Alendronate Sodium	141	50
Simvastatin	Simvastatin	133	44
Omeprazole	Omeprazole	129	44
Famotidine	Famotidine	122	65
Metformin Hcl Er	Metformin Hcl	104	35
Lidocaine	Lidocaine	99	45
Metformin Hcl	Metformin Hcl	99	40
Glipizide	Glipizide	95	34
Montelukast Sodium	Montelukast Sodium	90	31
Furosemide	Furosemide	89	33
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	86	34
Ibuprofen	Ibuprofen	84	45
Fluoxetine Hcl	Fluoxetine Hcl	81	23
Prednisone	Prednisone	79	70
Azelastine Hcl	Azelastine Hcl	78	44
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	72	11
Estradiol	Estradiol	71	35
Duloxetine Hcl	Duloxetine Hcl	70	24
Hydralazine Hcl	Hydralazine Hcl	68	27
Jardiance	Empagliflozin	58	16
Breyna	Budesonide/Formoterol Fumarate	55	31
Escitalopram Oxalate	Escitalopram Oxalate	55	21
Tamsulosin Hcl	Tamsulosin Hcl	55	23
Terazosin Hcl	Terazosin Hcl	50	18
Wixela Inhub	Fluticasone Propion/Salmeterol	50	18
Fluticasone Propionate	Fluticasone Propionate	49	17
Triamcinolone Acetonide	Triamcinolone Acetonide	49	30
Tramadol Hcl	Tramadol Hcl	48	15
Doxycycline Monohydrate	Doxycycline Monohydrate	46	46
Cephalexin	Cephalexin	44	36
Clobetasol Propionate	Clobetasol Propionate	43	16
Trazodone Hcl	Trazodone Hcl	43	19
Alvesco	Ciclesonide	42	26
Carvedilol	Carvedilol	42	15
Ozempic	Semaglutide	40	suppressed
Acyclovir	Acyclovir	39	21
Pregabalin	Pregabalin	38	suppressed
Spiriva Respimat	Tiotropium Bromide	37	13
Naproxen	Naproxen	36	12
Pradaxa	Dabigatran Etexilate Mesylate	35	13
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	34	34
Alprazolam	Alprazolam	34	suppressed
Citalopram Hbr	Citalopram Hydrobromide	34	12
Ondansetron Odt	Ondansetron	34	16
Ipratropium Bromide	Ipratropium Bromide	33	suppressed
Pravastatin Sodium	Pravastatin Sodium	33	13
Clopidogrel	Clopidogrel Bisulfate	31	suppressed
Ezetimibe	Ezetimibe	31	12
Lactulose	Lactulose	31	18
Tizanidine Hcl	Tizanidine Hcl	31	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	29	suppressed
Fenofibrate	Fenofibrate	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	28	11
Allopurinol	Allopurinol	27	suppressed
Mupirocin	Mupirocin	27	suppressed
Morphine Sulfate Er	Morphine Sulfate	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	25	suppressed
Nystatin	Nystatin	24	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	24	suppressed
Ciclopirox	Ciclopirox	23	14
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Sertraline Hcl	Sertraline Hcl	23	12
Venlafaxine Hcl	Venlafaxine Hcl	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	22
Humulin N	Insulin Nph Human Isophane	22	suppressed
Ibandronate Sodium	Ibandronate Sodium	22	11
Metoprolol Succinate	Metoprolol Succinate	21	suppressed
Metronidazole	Metronidazole	21	18
Spironolactone	Spironolactone	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Fluconazole	Fluconazole	20	19
Lubiprostone	Lubiprostone	20	suppressed
Naloxone Hcl	Naloxone Hcl	20	20
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Trospium Chloride	Trospium Chloride	19	11
Buspirone Hcl	Buspirone Hcl	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Retin-A	Tretinoin	18	suppressed
Etodolac	Etodolac	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	15	15
Lansoprazole	Lansoprazole	15	suppressed
Testosterone	Testosterone	15	suppressed
Baclofen	Baclofen	14	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Finasteride	Finasteride	14	suppressed
Liothyronine Sodium	Liothyronine Sodium	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Liraglutide	Liraglutide	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	12
Terbinafine Hcl	Terbinafine Hcl	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Verapamil Er	Verapamil Hcl	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Victoza 2-Pak	Liraglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error